These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Danlou Tablet Fought against Inflammatory Reaction in Atherosclerosis Rats with Intermingled Phlegm and Blood Stasis Syndrome and Its Mechanism Study]. Chen J; Cai HW; Miao J; Xu XM; Mao W Zhongguo Zhong Xi Yi Jie He Za Zhi; 2016 Jun; 36(6):703-8. PubMed ID: 27491230 [TBL] [Abstract][Full Text] [Related]
5. Randomized trial of an inhibitor of secretory phospholipase A2 on atherogenic lipoprotein subclasses in statin-treated patients with coronary heart disease. Rosenson RS; Elliott M; Stasiv Y; Hislop C; Eur Heart J; 2011 Apr; 32(8):999-1005. PubMed ID: 21081550 [TBL] [Abstract][Full Text] [Related]
6. Phospholipase A2 enzymes and the risk of atherosclerosis. Rosenson RS; Hurt-Camejo E Eur Heart J; 2012 Dec; 33(23):2899-909. PubMed ID: 22802388 [TBL] [Abstract][Full Text] [Related]
8. The synergistic inhibition of atherogenesis in apoE-/- mice between pravastatin and the sPLA2 inhibitor varespladib (A-002). Shaposhnik Z; Wang X; Trias J; Fraser H; Lusis AJ J Lipid Res; 2009 Apr; 50(4):623-9. PubMed ID: 19029066 [TBL] [Abstract][Full Text] [Related]
10. GM-CSF deficiency reduces macrophage PPAR-gamma expression and aggravates atherosclerosis in ApoE-deficient mice. Ditiatkovski M; Toh BH; Bobik A Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2337-44. PubMed ID: 16873730 [TBL] [Abstract][Full Text] [Related]
11. Role of group II secretory phospholipase A2 in atherosclerosis: 2. Potential involvement of biologically active oxidized phospholipids. Leitinger N; Watson AD; Hama SY; Ivandic B; Qiao JH; Huber J; Faull KF; Grass DS; Navab M; Fogelman AM; de Beer FC; Lusis AJ; Berliner JA Arterioscler Thromb Vasc Biol; 1999 May; 19(5):1291-8. PubMed ID: 10323782 [TBL] [Abstract][Full Text] [Related]
12. Low-carbohydrate diets reduce lipid accumulation and arterial inflammation in guinea pigs fed a high-cholesterol diet. Leite JO; DeOgburn R; Ratliff J; Su R; Smyth JA; Volek JS; McGrane MM; Dardik A; Fernandez ML Atherosclerosis; 2010 Apr; 209(2):442-8. PubMed ID: 19892353 [TBL] [Abstract][Full Text] [Related]
13. Simvastatin inhibits sPLA2 IIa expression in aorta and myocardium. Wei-hua L; Chang-qing S; Qiang X; Rong W; Kai-min L Arch Med Res; 2009 Feb; 40(2):67-72. PubMed ID: 19237014 [TBL] [Abstract][Full Text] [Related]
14. Granulocyte-macrophage colony-stimulating factor prevents the progression of atherosclerosis via changes in the cellular and extracellular composition of atherosclerotic lesions in watanabe heritable hyperlipidemic rabbits. Shindo J; Ishibashi T; Yokoyama K; Nakazato K; Ohwada T; Shiomi M; Maruyama Y Circulation; 1999 Apr; 99(16):2150-6. PubMed ID: 10217656 [TBL] [Abstract][Full Text] [Related]
15. Darapladib, a Lipoprotein-Associated Phospholipase A2 Inhibitor, Reduces Rho Kinase Activity in Atherosclerosis. Zhang J; Xu DL; Liu XB; Bi SJ; Zhao T; Sui SJ; Ji XP; Lu QH Yonsei Med J; 2016 Mar; 57(2):321-7. PubMed ID: 26847282 [TBL] [Abstract][Full Text] [Related]
16. Novel Role for Matrix Metalloproteinase 9 in Modulation of Cholesterol Metabolism. Hernandez-Anzaldo S; Brglez V; Hemmeryckx B; Leung D; Filep JG; Vance JE; Vance DE; Kassiri Z; Lijnen RH; Lambeau G; Fernandez-Patron C J Am Heart Assoc; 2016 Sep; 5(10):. PubMed ID: 27694328 [TBL] [Abstract][Full Text] [Related]
17. Analyses of group III secreted phospholipase A2 transgenic mice reveal potential participation of this enzyme in plasma lipoprotein modification, macrophage foam cell formation, and atherosclerosis. Sato H; Kato R; Isogai Y; Saka G; Ohtsuki M; Taketomi Y; Yamamoto K; Tsutsumi K; Yamada J; Masuda S; Ishikawa Y; Ishii T; Kobayashi T; Ikeda K; Taguchi R; Hatakeyama S; Hara S; Kudo I; Itabe H; Murakami M J Biol Chem; 2008 Nov; 283(48):33483-97. PubMed ID: 18801741 [TBL] [Abstract][Full Text] [Related]
18. Group v secretory phospholipase A2 promotes atherosclerosis: evidence from genetically altered mice. Bostrom MA; Boyanovsky BB; Jordan CT; Wadsworth MP; Taatjes DJ; de Beer FC; Webb NR Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):600-6. PubMed ID: 17204667 [TBL] [Abstract][Full Text] [Related]
20. Overexpression of Toll-Like Receptors 2, 3, 4, and 8 Is Correlated to the Vascular Atherosclerotic Process in the Hyperlipidemic Rabbit Model: The Effect of Statin Treatment. Kapelouzou A; Giaglis S; Peroulis M; Katsimpoulas M; Moustardas P; Aravanis CV; Kostakis A; Karayannakos PE; Cokkinos DV J Vasc Res; 2017; 54(3):156-169. PubMed ID: 28478461 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]